Krissanaprasit A, Mihalko E, Meinhold K, Simpson A, Sollinger J, Pandit S
Mol Ther. 2024; 32(7):2286-2298.
PMID: 38720458
PMC: 11286819.
DOI: 10.1016/j.ymthe.2024.05.002.
Nagano M, Kubota K, Sakata A, Nakamura R, Yoshitomi T, Wakui K
Mol Ther Nucleic Acids. 2023; 33:762-772.
PMID: 37621412
PMC: 10445101.
DOI: 10.1016/j.omtn.2023.07.038.
Krissanaprasit A, Key C, Froehlich K, LaBean T
Methods Mol Biol. 2023; 2639:339-350.
PMID: 37166725
DOI: 10.1007/978-1-0716-3028-0_18.
Silwal A, Thennakoon S, Arya S, Postema R, Jahan R, Phuoc C
Theranostics. 2022; 12(12):5522-5536.
PMID: 35910791
PMC: 9330529.
DOI: 10.7150/thno.74428.
Amini R, Zhang Z, Li J, Gu J, Brennan J, Li Y
Anal Sens. 2022; 2(5):e202200012.
PMID: 35574520
PMC: 9082509.
DOI: 10.1002/anse.202200012.
Beyond G-Quadruplexes-The Effect of Junction with Additional Structural Motifs on Aptamers Properties.
Kotkowiak W, Pasternak A
Int J Mol Sci. 2021; 22(18).
PMID: 34576112
PMC: 8466185.
DOI: 10.3390/ijms22189948.
A SARS-CoV-2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD-Independent Mechanism.
Schmitz A, Weber A, Bayin M, Breuers S, Fieberg V, Famulok M
Angew Chem Weinheim Bergstr Ger. 2021; 133(18):10367-10373.
PMID: 34230708
PMC: 8250900.
DOI: 10.1002/ange.202100316.
Design strategy of antidote sequence for bivalent aptamer: Rapid neutralization of high-anticoagulant thrombin-binding bivalent DNA aptamer-linked M08 with HD22.
Yoshitomi T, Wakui K, Miyakawa M, Yoshimoto K
Res Pract Thromb Haemost. 2021; 5(5):e12503.
PMID: 34136744
PMC: 8178692.
DOI: 10.1002/rth2.12503.
Structural Biology for the Molecular Insight between Aptamers and Target Proteins.
Zhang N, Chen Z, Liu D, Jiang H, Zhang Z, Lu A
Int J Mol Sci. 2021; 22(8).
PMID: 33920991
PMC: 8071422.
DOI: 10.3390/ijms22084093.
A SARS-CoV-2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD-Independent Mechanism*.
Schmitz A, Weber A, Bayin M, Breuers S, Fieberg V, Famulok M
Angew Chem Int Ed Engl. 2021; 60(18):10279-10285.
PMID: 33683787
PMC: 8251191.
DOI: 10.1002/anie.202100316.
Functional and Structural Characterization of Nucleic Acid Ligands That Bind to Activated Coagulation Factor XIII.
Hamedani N, Biswas A, Rudan O, Tonges R, Meyring C, Tolle F
J Clin Med. 2021; 10(4).
PMID: 33578732
PMC: 7916480.
DOI: 10.3390/jcm10040677.
A DNA origami-based aptamer nanoarray for potent and reversible anticoagulation in hemodialysis.
Zhao S, Tian R, Wu J, Liu S, Wang Y, Wen M
Nat Commun. 2021; 12(1):358.
PMID: 33441565
PMC: 7807036.
DOI: 10.1038/s41467-020-20638-7.
Dimeric and Multimeric DNA Aptamers for Highly Effective Protein Recognition.
Riccardi C, Napolitano E, Musumeci D, Montesarchio D
Molecules. 2020; 25(22).
PMID: 33182593
PMC: 7698228.
DOI: 10.3390/molecules25225227.
Evolution of a highly functional circular DNA aptamer in serum.
Mao Y, Gu J, Chang D, Wang L, Yao L, Ma Q
Nucleic Acids Res. 2020; 48(19):10680-10690.
PMID: 33021630
PMC: 7641760.
DOI: 10.1093/nar/gkaa800.
Tuning the Polymorphism of the Anti-VEGF G-rich V7t1 Aptamer by Covalent Dimeric Constructs.
Riccardi C, Musumeci D, Platella C, Gaglione R, Arciello A, Montesarchio D
Int J Mol Sci. 2020; 21(6).
PMID: 32183039
PMC: 7139925.
DOI: 10.3390/ijms21061963.
Unraveling Determinants of Affinity Enhancement in Dimeric Aptamers for a Dimeric Protein.
Manochehry S, McConnell E, Li Y
Sci Rep. 2019; 9(1):17824.
PMID: 31780794
PMC: 6883073.
DOI: 10.1038/s41598-019-54005-4.
Rapidly Neutralizable and Highly Anticoagulant Thrombin-Binding DNA Aptamer Discovered by MACE SELEX.
Wakui K, Yoshitomi T, Yamaguchi A, Tsuchida M, Saito S, Shibukawa M
Mol Ther Nucleic Acids. 2019; 16:348-359.
PMID: 30986696
PMC: 6462803.
DOI: 10.1016/j.omtn.2019.03.002.
Dimerization of an aptamer generated from Ligand-guided selection (LIGS) yields a high affinity scaffold against B-cells.
Batool S, Argyropoulos K, Azad R, Okeoma P, Zumrut H, Bhandari S
Biochim Biophys Acta Gen Subj. 2018; 1863(1):232-240.
PMID: 30342154
PMC: 6248343.
DOI: 10.1016/j.bbagen.2018.10.006.
Bioapplications of Cell-SELEX-Generated Aptamers in Cancer Diagnostics, Therapeutics, Theranostics and Biomarker Discovery: A Comprehensive Review.
Pang X, Cui C, Wan S, Jiang Y, Zhang L, Xia L
Cancers (Basel). 2018; 10(2).
PMID: 29425173
PMC: 5836079.
DOI: 10.3390/cancers10020047.
Construction of a Bivalent Thrombin Binding Aptamer and Its Antidote with Improved Properties.
Hughes Q, Le B, Gilmore G, Baker R, Veedu R
Molecules. 2017; 22(10).
PMID: 29048375
PMC: 6151750.
DOI: 10.3390/molecules22101770.
